TrialFrontiers in immunology2023

Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma.

Jinpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.